Feature | August 27, 2012

Study Shows CT is Superior for Indicating Cardiovascular Risk

A new? study indicates the CT coronary artery calcium score is the superior test for accurately predicting cardiovascular risk and disease in adults at intermediate risk for heart disease

August 27, 2012 - A recent multi-center study, led by researchers from Wake Forest School of Medicine and published in the Journal of the American Medical Association (JAMA) has indicated that computed tomography (CT) scanning of the heart and measuring the coronary artery calcium (CAC) score is the most accurate predictor of cardiovascular disease for individuals at intermediate risk for heart disease.

The study included 1,300 individuals with intermediate cardiovascular risk factors (excluding diabetes) based on the Framingham Risk Score (FRS), who were followed over a period of seven years as part of the National Heart, Lung and Blood Institute's Multi-Ethnic Study of Atherosclerosis (MESA). MESA is an observational study of cardiovascular disease performed at six sites across the United States.
 
Six novel or established markers of heart disease risk were directly compared. These included the CT CAC score, ankle-brachial index, brachial flow mediated dilation, carotid intima-media thickness, high sensitivity C-reactive protein and family history of heart disease. CAC score, determined by CT scan, held the highest predictive association for cardiovascular disease.
 
According to Jeffery J. Carr, M.D., MSc, a co-author on the publication and president-elect of the Society of Cardiovascular Computed Tomography (SCCT), "This work demonstrates that the calcium score outperforms these widely studied tests and even family history in the prediction of future heart attacks and cardiovascular death. For healthcare providers, we have the first direct comparison of these tests. This new evidence will help in advising our patients when additional information is needed to refine an individual's risk of heart disease. In many cases, no additional testing is needed; however, for those important cases where refining our understanding of risk of heart disease is critical to medical decision-making, the cardiac CT measured calcium score is a clear winner as relates to future risk for an individual."
 
Although CAC scans indicated the highest level of accuracy in predicting cardiovascular risk, factors such as cost and the level of risk due to radiation exposure from CT scan will be future considerations in research.
 
For more information, visit www.SCCT.org
 

Related Content

smartphones, hospital tranfers, heart attack patients, JACC study, South Korea
News | Mobile Devices| September 23, 2016
Smartphone communication among medical teams at different hospitals can significantly reduce the time it takes for...
Medtronic, In.Pact Admiral drug-coated balloon, trial data, VIVA
News | Drug-Eluting Balloons| September 22, 2016
New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the durability, consistency...
Medtronic, CRT, cardiac resynchroniazation therapy devices, heart failure, medication adherence, retrospective analysis, HFSA 2016
News | Heart Failure| September 20, 2016
Medtronic plc announced the results of an analysis that reveals patients increasingly adhere to heart failure...
Valtech Cardio, Cardioband Tricuspid, Cardioband Mitral, PCR London Valves 2016, study data
News | Heart Valve Technology| September 19, 2016
Valtech Cardio Ltd. announced that it will present the first-in-man data for its Cardioband Tricuspid (TR) system at...
EBR Systems, FDA, WiSE Technology, Wireless Stimulation Endocardially, SOLVE-CRT study

The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional cardiac resynchronization therapy (CRT) in heart failure patients. Graphic courtesy of Business Wire.

News | Cardiac Resynchronization Therapy Devices (CRT)| September 15, 2016
EBR Systems Inc. announced the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption...
News | Cardiac Diagnostics| September 13, 2016
September 13, 2016 — Results from a new study suggest that small molecules known as microRNAs may be part of the path
News | Cardiac Diagnostics| September 13, 2016
September 13, 2016 — Findings from a small...
News | Cardiac Diagnostics| September 12, 2016
A Saint Louis University researcher has received a grant to study the effects of treating post-traumatic stress...
congenital heart defects, CHD, risk factors, genes, University of California Irvine research
News | Congenital Heart| September 09, 2016
September 9, 2016 — New research published Sept.
Carmat, bioprosthetic artificial heart, PIVOTAL study, first implantation, heart failure
News | Artificial Heart| September 09, 2016
Carmat announced that the first implantation of its bioprosthetic artificial heart within the framework of the PIVOTAL...
Overlay Init